Your Record Was Built For People
Who Already Know What You Do.
A clinical CV confirms what the system already expects. It doesn't tell a corporate board, a private sector panel, or a headhunter why you belong in the room.
What you're looking at is an example Career Memorandum, constructed to show how the format works for a senior clinician moving into board-level and private sector roles. The candidate, credentials, and figures are illustrative.
Why the format works differently
for clinical careers.
Medicine has its own language of credibility. That language is essential inside the system. Outside it, it stops working almost entirely.
The gap between what your CV communicates to a medical recruiter and what it communicates to a corporate board is wider in clinical careers than almost any other sector. This document bridges it.
Dr James Okafor
FRCP Β· PhD Β· Medical Director Β· Non-Executive Director
A clinical and
executive record.
Dr James Okafor is a consultant physician and NHS executive leader with eighteen years of concurrent clinical and leadership practice. Fellow of the Royal College of Physicians. PhD in Medical Sciences from the University of Leeds (2012), on sepsis biomarker stratification in acute medicine β research subsequently cited in the evidence base for NICE Guideline NG94. Undergraduate training at the University of Birmingham School of Medicine and Dentistry.
Appointed Medical Director of Mercia University Hospitals NHS Foundation Trust in 2016, with the Trust rated Requires Improvement across three of five CQC domains. Six-year tenure as a full voting member of the Board of Directors. Led the Trust from Requires Improvement to Good in year three and to Outstanding in year six, against a Β£52m transformation programme spanning clinical governance, patient safety, medical workforce, and digital infrastructure. Serious incidents reduced from 47 per annum at appointment to 18 in the final year. Zero Never Events in years four through six.
Research-active throughout executive tenure. 28 peer-reviewed publications indexed on PubMed. Invited contributor to NICE NG94 β Sepsis: Recognition, Diagnosis and Early Management β and member of the clinical expert panel for NICE NG185 on the long-term effects of COVID-19. Post-COVID rehabilitation service at Mercia recognised as a national exemplar pathway by NHS England in 2022.
Since stepping down as Medical Director in 2022, holds a portfolio of three concurrent appointments: NED and Remuneration Committee member at a private healthcare group operating eleven specialist hospitals across the UK and Ireland; Associate NED at a teaching Foundation Trust through the NHS Providers NED development programme; and Clinical Advisory Board member for an acute patient safety software platform targeting NHS patient safety improvement procurement pathways.
Working language: English (native). GMC Full Registration maintained throughout. Elected registrar representative to the Royal College of Physicians Junior Doctors Committee, 2006β2008.
Eighteen years.
Aggregate record.
Full career
record.
- Appointed to a board conducting an active clinical governance review β the only NED with substantive NHS executive and CQC regulatory experience across the eleven-hospital estate.
- Remuneration Committee member from first board cycle; contributes to senior clinical and executive reward frameworks across the group, including consultant contract terms and the Group Medical Director appointment process.
- Patient safety advisory mandate covers all eleven hospital sites. Working within the group's internal independent sector CQC registration framework; advising on patient safety governance structures in the context of CQC's 2021β2026 regulatory strategy.
- Contributed to the board's response to a CQC requirement notice at one of the group's surgical units β chaired the clinical sub-group; notice resolved within 6 months of appointment.
- Quality and Safety Committee member; contributes to the review of serious incident investigations, Never Event reports, and NHS Patient Safety Improvement Programme implementation at the Trust.
- Brings direct CQC inspection experience β has led a Trust through three comprehensive inspections as the executive accountable officer β to a board that has not undergone a comprehensive inspection since 2019.
- Contributing to the Trust's medical workforce planning review, drawing on experience of reducing consultant vacancy rates from 19% to 7% at Mercia; initial analysis shared with the Chief People Officer in Q1 2024.
- Providing clinical validation for the platform's early warning algorithm β drawing directly on NHS experience implementing the Patient Safety Improvement Programme and Martha's Rule at Mercia. Algorithm design reviewed against clinical evidence from the NEWS2 framework literature.
- Contributing to the company's NHS procurement strategy, specifically the route through the NHS Digital Health Technology Assessment process and alignment with the NHS England Patient Safety CQUIN specifications.
- Advisory board fee income declared to both NHS Foundation Trust registers of interest before appointment β confirmed no conflict in either role.
- Led the Trust from CQC Requires Improvement to Good in year three and Outstanding in year six β one of 17 NHS Trusts nationally to hold an Outstanding rating at the time of assessment.
- Serious incidents reduced from 47 per annum at appointment to 32 in year three and 18 in year six β a 62% reduction across the tenure. Zero Never Events in years four through six. Implemented Martha's Rule early warning framework across all adult inpatient wards from 2021; one of 143 acute trusts in the pilot wave.
- Chaired the Board-level Quality and Safety Committee for six years. Annual Quality Account published without qualification in every year of tenure; reviewed and signed off by the Council of Governors.
- Led the Trust through three CQC comprehensive inspections, two NHS England oversight reviews, and one NHS Improvement enforcement undertaking β resolved without formal regulatory action. NHS England Patient Safety Improvement Plan formally closed as complete in year four.
- Aligned the Trust's patient safety programme to the NHS Patient Safety Strategy (2019). Implemented the Patient Safety Improvement Programme across all clinical directorates in year one of the strategy.
- Reduced consultant vacancy rate from 19% to 7% over four years through a clinical leadership development programme and a revised medical appraisal framework. Recognised by the NHS Confederation as a national exemplar for clinical workforce retention in year five of the Medical Director tenure.
- Staff survey engagement score moved from bottom national quartile to top decile β 56% engagement at appointment; 94% in the final year. Achieved in the context of two rounds of consultant job planning reviews and the 2016 junior doctor contract implementation.
- Appointed to the Integrated Care System Clinical Leadership Group, representing the Trust across a system covering 1.4 million patients. Led the development of the ICS clinical strategy across three priority pathways β urgent care, mental health, and elective recovery β in alignment with the NHS Long Term Plan.
- Led junior doctor contract negotiations with the BMA Local Negotiating Committee on the 2016 contract implementation β zero industrial action at the Trust during the national dispute period that saw 22 days of strike action across other NHS trusts in the region.
- Oversaw the Β£52m transformation programme across six years: new 12-bed ICU expansion, surgical theatre refurbishment, and digital patient safety infrastructure rollout across all inpatient wards β including the electronic prescribing system implementation completed in year five.
- Led the clinical governance restructure that preceded the 2016 CQC inspection β redesigned the serious incident review framework, reducing the backlog of open SI investigations from 34 to 7 in 9 months.
- Rebuilt the Trust's medical appraisal framework following a Responsible Officer review that identified 43 consultants with incomplete appraisal records. Full compliance achieved within 12 months; framework audited and confirmed compliant by NHS England regional team.
- Introduced a Trust-wide consultant job planning review β identified 11 FTE of consultant capacity absorbed by non-clinical administrative tasks; reassigned to direct patient care. Estimated value: Β£780k per annum in restored clinical capacity at average consultant job plan cost.
- Chaired the Mortality Review Committee for three years. Introduced HSMR monitoring linked to the Quality and Safety Committee reporting dashboard. Trust HSMR moved from 108 (above expected range) to 96 (within expected range) over the period.
- Led the Trust's response to a CQC requirement notice arising from the 2014 inspection β 14 requirements addressed and evidenced within the 6-month remediation period. CQC formally confirmed all requirements met at the 2015 follow-up inspection.
- Designed and implemented the Trust's first Frailty at the Front Door pathway (2014β2015) β reduced acute admissions in the over-75 cohort by 18% against the prior year baseline; average length of stay in that cohort fell from 8.4 to 6.1 days within 12 months of implementation.
- Appointed as Clinical Lead, Acute Medicine Directorate from 2010 to 2013 β managed a directorate of 18 consultants, 42 middle-grade doctors, and a Β£14m annual operating budget. Directorate achieved its first clean HSMR result within the expected range under the clinical lead appointment.
- Invited contributor to NICE Guideline NG94 β Sepsis: Recognition, Diagnosis and Early Management (published 2016). Contributed clinical evidence to the acute medicine and emergency care sections; PhD research cited in the guideline evidence review. Trust implementation of NG94 reduced sepsis mortality at Mercia by 22% over two years against the pre-protocol baseline, measured using the UK Sepsis Trust audit methodology.
- Appointed to the clinical expert panel for NICE Guideline NG185 β Managing the Long-term Effects of COVID-19 (published 2020). Contributed evidence from the Trust's post-COVID rehabilitation service; service subsequently recognised as a national exemplar pathway by NHS England in 2022.
- PhD in Medical Sciences, University of Leeds (2012) β "Sepsis Biomarker Stratification in Acute Medicine: a prospective cohort study." Supervised by Professor Sarah Linton, Leeds Institute of Medical Research. Thesis contributed to the evidence base subsequently cited in NICE NG94.
- Elected to the Royal College of Physicians Acute Medicine Specialist Advisory Committee, 2011β2014. Contributed to curriculum review, training programme standards, and assessment framework for the Certificate of Completion of Training in Acute Internal Medicine.
- 28 peer-reviewed publications indexed on PubMed, including primary research in sepsis pathway management, acute care workforce planning, and patient safety systems design. Selected publications listed below.
- Designed the Trust's first Frailty at the Front Door clinical pathway in 2014 β piloted within the acute medicine directorate before Trust-wide rollout under the Deputy MD role.
- MRCP Part 1, Part 2 Written, and PACES β all passed at first attempt, 2007.
- Elected registrar representative to the Royal College of Physicians Junior Doctors Committee, 2006β2008. Contributed to the Core Medical Training curriculum review and to the RCP's response to the Modernising Medical Careers consultation.
- Three peer-reviewed papers published during registrar training, including first-author primary research on sepsis recognition in the acute medical unit, published in Clinical Medicine (RCP) in 2007 β establishing the research line pursued in the subsequent PhD.
- Six-month out-of-programme research attachment at the University of Leeds (2007), working within the Leeds Institute of Medical Research under Professor Sarah Linton. Attachment established the academic relationship that led to the part-time PhD programme from 2008.
- Completed the NHS Leadership Academy Frontline Leaders programme during the registrar rotation β first cohort from the East Midlands Deanery to complete the programme.
- FY1 rotations: acute medicine at Queen Elizabeth Hospital Birmingham, general surgery at Heartlands Hospital, and general practice placement in South Birmingham. FY2 rotations: acute medicine, emergency medicine, and obstetrics and gynaecology.
- Elected to the Foundation Programme Committee representative role in year two β contributed to the FY2 curriculum review across the UHB training programme; first foundation doctor to be elected to the committee from the acute medicine rotation.
- First-author case report on an unusual presentation of septic shock published in BMJ Case Reports during FY2 year β establishing the research interest in sepsis that ran through the registrar training and PhD.
Academic and
professional record.
Clinical and
governance domains.
Clinical & Regulatory
Board, Advisory & Research
Direct
contact.
All three current appointments (Sovereign Health Group, Northgate Teaching Hospitals NHS FT, Sentinal Health Technologies) are disclosed to the relevant registers of interest. No conflicts of interest have been identified. GMC Full Registration current. Medical revalidation completed on schedule throughout consultant tenure.